Company: PCRX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001396814-25-000041
Chunk: 65

Company: Pacira BioSciences, Inc.
Filing Date: 2025-02-27
Form: 10-K
Item: Item 16
Chunk 65
---
Black-Scholes Weighted Average Assumption202420232022Expected dividend yieldNoneNoneNoneRisk-free interest rate3.55% - 4.58%3.05% - 4.81%1.37% - 4.17%Expected volatility40.6%41.3%45.1%Expected term of options5.15 years4.90 years4.92 yearsThe following table summarizes the Company’s RSU activity and related information for the year ended December 31, 2024: Number ofRestricted Stock UnitsWeightedAverage GrantDate Fair Value (Per Share)AggregateIntrinsic Value(in Thousands)Unvested at  December 31, 20231,364,618 $47.66 $46,042 Granted2,198,365 27.29 Vested(500,785)48.78 Forfeited(292,470)40.04 Unvested and expected to vest as of December 31, 20242,769,728 $32.07 $52,182 As of December 31, 2024, $70.6 million of total unrecognized compensation cost related to unvested RSUs is expected to be recognized over a weighted average period of 1.7 years. The Company’s RSUs have a maximum vest date of four years from the date of grant. The fair values of RSUs awarded are equal to the closing price of the Company’s common stock on the date of grant.The fair values of the ESPP share options granted were estimated using the Black-Scholes model with the following weighted average assumptions:

Pacira BioSciences, Inc.  |  2024 Annual Report on Form 10-K  |  Page F-35

Table of ContentsPACIRA BIOSCIENCES, INC.NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Year Ended December 31,Black-Scholes Weighted Average Assumption202420232022ESPP share option fair value$8.20 - $8.25$10.00 - $10.34$15.26 - $15.86Expected dividend yieldNoneNoneNoneRisk-free interest rate5.33% - 5.26%4.77% - 5.53%0.22% - 2.52%Expected volatility40.5%35.4%39.5%Expected term of ESPP share options6 months6 months6